Illumina announced that its first NovaSeq X Plus system was recently delivered to the Broad Institute. Seen here is Broad's sequencing operations team with their new NovaSeq X Plus.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow ...

Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that incorporate the tech and chemistry used by its largest, top-of-the-line machines.

In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...

Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs.

The sequencers began shipping in December, and simultaneously the company introduced the software v1.3 upgrade for the NovaSeq X Series to elevate sequencing performance and advance data quality.

Business Strategy and Outlook Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications.

The NovaSeq X Series is Illumina's most powerful sequencing system, delivering an unprecedented combination of high throughput and accuracy, and featuring streamlined informatics, breakthrough ...

Genomics giant Illumina launched a new line of DNA sequencers, ratcheting up the race to read genetic information accurately and cheaply.

It currently costs roughly $600 to sequence an entire genome, compared to about $10,000 10 years ago, according to the story. Illumina revealed its NovaSeq X sequencing machine at an industry ...

Illumina Sequencing The CWRU Genomics Core offers the highly trusted Illumina platforms for all Next-Gen Sequencing (NGS) services. From amplicon sequencing to sequencing human genomes, the core has ...